Wholehealth Products Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Charles Strongo
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 11.1yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2017 | US$1m | US$150k | -US$3m |
Compensation vs Market: Insufficient data to establish whether Charles's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Charles's compensation with company performance.
CEO
Charles Strongo (60 yo)
11.1yrs
Tenure
US$1,195,000
Compensation
Mr. Charles A. Strongo, BA, MBA, served as Chief Executive Officer and Director at Nunzia Pharmaceutical Corporation since December 05, 2019 until 2022 and also served as its Chairman since 2019 until 2022...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.1yrs | US$1.20m | no data | |
| CFO, Treasurer & Director | 11.1yrs | US$415.00k | no data | |
| Director | no data | no data | no data | |
| Director | 11.1yrs | no data | no data | |
| Director | no data | no data | no data |
11.1yrs
Average Tenure
82yo
Average Age
Experienced Board: GWPC's board of directors are seasoned and experienced ( 11.1 years average tenure).